Clostridioides Difficile Infection
The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioid…
Phoenix, United StatesEst. completion Apr 20, 2027
Clostridoides Difficile Associated Disease
The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile…
Athens, United StatesEst. completion Dec 11, 2028
Recurrent Clostridioides Difficile InfectionColonic Surgery
This is a single-center, open-label study for safety and feasibility of IMT in patients undergoing colonic surgery. Afte…
Minneapolis, United StatesEst. completion Dec 1, 2027
Clostridium Difficile Colitis
It has been shown that restoration of the normal makeup of the bowel bacterial population is the most effective way to t…
Durham, United StatesEst. completion May 2027
Clostridium Difficile Infections
Clostridium difficile infection (CDI) is a major cause of infectious diarrhea and the most important cause of nosocomial…
Paris, FranceEst. completion Jan 4, 2029
Clostridium Difficile Infection Recurrence
Single-arm trial to evaluate the safety and efficacy of ACX-362E \[ibezapolstat\] in patients with recurrent C. difficil…
Sacramento, United StatesEst. completion Sep 29, 2027
Clostridioides Difficile InfectionRecurrent Infection
Clostridioides difficile infection (CDI) is the leading cause of nosocomial diarrhea in Europe, with over 120,000 cases …
Annecy, FranceEst. completion Jan 7, 2028
Clostridium DifficileClostridium Difficile InfectionsClostridium Difficile Infection RecurrenceClostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceCDIC. Diff InfectionRecurrent Clostridium Difficile InfectionC.Difficile DiarrheaDiarrhea Infectious
The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (…
Huntsville, United StatesEst. completion Jun 2027
Clostridioides Difficile Infection
The clinical trial aims to evaluate the efficacy of fecal microbiota transplantation (FMT) after standard of care treatm…
Basel, SwitzerlandEst. completion Apr 1, 2027
Clostridioides Difficile Infection
This study aims to evaluate the impact of diet on the gut microbiome in adults with Clostridioides difficile infection (…
Ann Arbor, United StatesEst. completion Dec 2027
Clostridia Difficile Colitis
Indirect evidence from network meta-analyses of randomized controlled trials (RCTs) suggest that a pulse and taper (P-T)…
Montreal, CanadaEst. completion Jun 1, 2030
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
Re-exposure to systemic antibiotics (i.e., antibiotics absorbed into the bloodstream) is common after a Clostridioides d…
Montreal, CanadaEst. completion Oct 1, 2028
Ulcerative Colitis
Ulcerative Colitis (UC) is a chronic Inflammatory Bowel Disease characterized by chronic inflammation of the colon. Comp…
Paris, FranceEst. completion Jun 2029
Clostridioides Difficile Infection Recurrence
Hospitals and clinics interested in participating in this multi-site study, please contact the people mentioned under "C…
Atlanta, United StatesEst. completion Oct 15, 2026
Ulcerative ColitisInflammatory Bowel DiseasesClostridioides Difficile Infection
This is a multi-centre, randomised controlled trial comparing fecal microbiota transplantation to placebo in an expanded…
Calgary, CanadaEst. completion Mar 1, 2028
Clostridioides Difficile Infection RecurrenceFMT
Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.
Helsinki, FinlandEst. completion Dec 31, 2029
Clostridium DifficileUlcerative Colitis
Clostridioides difficile infection (CDI) is the most frequent cause of infectious diarrhea in hospitalized patients and …
Rome, ItalyEst. completion Sep 24, 2026
Clostridioides Difficile Infection Recurrence
Clostridioides difficile infection (CDI) is the most common cause of nosocomial diarrhea, and the most common health care-…
Roma, ItalyEst. completion Feb 14, 2027
C. Difficile
Clostridioides difficile (C. difficile) is the most common healthcare-associated pathogen, causing \>500,000 infections …
Boston, United StatesEst. completion Jun 1, 2025
Clostridium Difficile Infections
Clostridioides difficile (formerly Clostridium) is a bacterium found in the form of spores (resistance form) in the envi…
Paris, FranceEst. completion Nov 17, 2026